The study also pointed out significantly higher expressions of immunoreceptors, including CXCR4, CCR5, and CXCR3, in the high-risk group, indicating a complex interplay of immune responses associated with NB progression risk (Fig. 9F). This evidence concerns the gene CXCR3 and neuroblastoma.